物质信息

ID:1824873

名称和标识
IUPAC标准名
(4R,5S,6S)-3-{[(3S,5S)-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl]sulfanyl}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
别名
ertapenem(1R,5S,6S,8R,2'S,4'S)-2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid(4R,5S,6S)-3-((3S,5S)-5-((3-carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acidERTAPENEM
国际非专利药品(INN)
ertapenem
IUPAC传统名
ertapenem
数据登录号
PubChem CID
ACToR数据库
BKMS React数据库
BRENDA Ligand数据库
CompTox数据库
SABIO-RK数据库
SureChEMBL数据库
Beilstein号
维基百科标题
DrugBank ID
Drug Central Database
KEGG DRUG Database
PubChem SID
化合物性质
暂无数据
点击上传数据
描述信息
Meropenem in which the one of the two methyl groups attached to the amide nitrogen is replaced by hydrogen while the other is replaced by a 3-carboxyphenyl group. The sodium salt is used for the treatment of moderate to severe susceptible infections including intra-abdominal and acute gynaecological infections, pneumonia, and infections of the skin and of the urinary tract.
分子图谱
暂无数据
点击上传数据
参考文献
暂无数据
点击上传数据